Filing Details
- Accession Number:
- 0001209191-17-046040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-24 06:15:13
- Reporting Period:
- 2017-07-20
- Filing Date:
- 2017-07-24
- Accepted Time:
- 2017-07-24 06:15:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1042074 | Cymabay Therapeutics Inc. | CBAY | Pharmaceutical Preparations (2834) | 943103561 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1588861 | Sujal Shah | C/O Cymabay Therapeutics, Inc. 7999 Gateway Boulevard, Suite 130 Newark CA 94560 | Interim President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-20 | 891 | $7.29 | 75,891 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-20 | 400 | $7.30 | 76,291 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-20 | 576 | $7.31 | 76,867 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-20 | 100 | $7.32 | 76,967 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-20 | 8,033 | $7.35 | 85,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
